Regulators Intensify Scrutiny of Compounded GLP-1 Advertising as Industry Grows
Advertising for compounded GLP-1 weight loss products is facing increased scrutiny as regulators respond to the rapid expansion of telehealth ...
Read MoreEli Lilly Seeks FDA Approval for Oral GLP-1 After Maintenance Trial Results
If you have ever followed GLP-1 news, you have probably noticed the same pattern that shows up again and again. ...
Read MoreProRx Under FDA Scrutiny: What the Warning Letter and Recall Mean
ProRx has recently come under FDA scrutiny following an inspection of its facility and the publication of an FDA Warning ...
Read More
Novo Nordisk’s Wegovy® Goes Telehealth – And Why Compounded GLP-1s Aren’t Going Anywhere
If you read the headlines this week and thought, “Wait, does this mean compounded GLP-1 meds are over?” you're wrong… ...
Read More
Munich to Host 25th International AIDS Conference in 2024
Munich, Germany will be the host city for the 25th International AIDS Conference, AIDS 2024 from July 22-26. Thousands will ...
Read More